Boston—There is no sign of slowing in the specialty drug development market, according to a presentation by an Express Scripts expert at the Academy of Managed Care Pharmacy’s Managed Care & Specialty Pharmacy annual meeting.
“We’re seeing greater and greater competition among specialty pharmaceuticals, particularly as more generics and biosimilars are approved,” said Aimee Tharaldson, PharmD, a senior clinical consultant on emerging therapeutics at